Announcing Argus II Retinal Prosthesis System
First Patients Receive Commercial Implant of Argus II Bionic Retina
FFB in the News
Numerous major news outlets reported on FDA approval of the Argus II and turned to the Foundation as a resource on this advancement. Check us out:
Jan. 29, 2014 - A grandmother of 10 who was diagnosed with retinitis pigmentosa (RP) 25 years ago is one of the first two people to receive an implant of the Argus® II Retinal Prosthesis System since it became commercially available in the United States. She is hopeful that the device, when activated after she recovers from surgery and receives training, will enable her to travel more and see the movement and activity of her grandchildren.
Also known as a bionic retina, the device was developed by the company Second Sight and approved by the U.S. Food and Drug Administration last February. But until now, the artificial retina had only been used by participants in clinical trials. A video featuring the doctors who perfomed the implants is available below.
Vision-Restoring Retinal Prosthesis Receives FDA Approval
The Argus II retinal prosthesis, a device that can restore some vision to people who are blind from advanced retinitis pigmentosa (RP), has received U.S. market approval from the Food and Drug Administration (FDA). Developed by Second Sight Medical Products, the device will be available later this year in approximately 10 clinical centers across the country. In 2011, the Argus II received marketing approval in Europe. Also known as a “bionic retina,” it is currently the world’s only retinal prosthesis with regulatory approval. Read More..
Stories of Hope
Getting Better All the TimeThe story of how the Argus II retinal prosthesis—just approved by the FDA—shed light on one Englishman’s life after decades of darkness. Read More..
From Our Blog
How an FDA-Approved Retinal Prosthesis Came To Be
The CEO and co-founder of Second Sight, the company that created the “Argus II,” recounts the system’s two-decade history. Read More..